EPCT-06. A PHASE I STUDY OF MULTI-TARGETED THERAPY IN NEWLY DIAGNOSED OR PROGRESSIVE DIFFUSE INTRINSIC PONTINE GLIOMA

BACKGROUND: Diffuse intrinsic pontine glioma (DIPG) constitutes 80% of pediatric brain stem tumors with a median survival of 12 months. The PI3K/AKT/mTOR pathway is a key oncogenic driver of this tumor. Targeting the chromatin dysregulation through HDAC inhibition, demonstrated benefit in vivo and v...

Descripción completa

Detalles Bibliográficos
Autores principales: Baig, Muhammad, Johnson, Jason, Gupta, Sumit, Sadighi, Zsila, Zaky, Wafik, Khatua, Soumen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Early Phase Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715368/
http://dx.doi.org/10.1093/neuonc/noaa222.130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715368/
http://dx.doi.org/10.1093/neuonc/noaa222.130

Ejemplares similares